Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ceftazidime for Injection

Approval Number

国药准字H20033104

Company珠海联邦制药股份有限公司中山分公司

Registration Date

March 3, 2020

Drug Information

Generic Name

注射用头孢他啶

Brand Name

联邦

Dosage Form

注射剂

Strength

1.0g（按C₂₂H₂₂N₆O₇S₂计）

Drug Type

化学药品

Registration Date

March 3, 2020

Company Information

Applicant Company

Company Name珠海联邦制药股份有限公司中山分公司

Company Address

广东省中山市坦洲镇嘉联路12号

Manufacturing Company

Company Name珠海联邦制药股份有限公司中山分公司

Company Address

广东省中山市坦洲镇嘉联路12号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy